Orthopedics devices maker ConforMIS is in a fund-raising frenzy, raising $113.8 million since 2011 to develop its custom joint implant technology, according to regulatory filings.
ConforMIS launched a new funding round last week aimed at raising another $68 million, which had yet to notch a first investor, according to an SEC filing.
In a separate filing submitted this week, the device maker amended a $98 million funding round initially launched in June 2011, reporting $41.2 million raised from 61 unnamed investors.
And a 3rd filing issued this month amended an $84 million round initially launched in October 2011, noting $72.7 million raised among 13 investors.
The funds will go toward "working capital and potential business transactions," according to SEC documents.
The company earlier this year closed a $89 million Series E funding round to support its line of custom knee products.
CEO Phillip Lang told MassDevice.com at the time that proceeds from that round, which closed in October, were slated for the build-out of a direct sales force for its line of personalized knee implants. Land added that the company plans to use a significant amount of the cash to launch new joint replacement products this year.
ConforMIS declined to comment today on the latest fund-raising reports.
